First Time Loading...
C

Celltrion Healthcare Co Ltd
KOSDAQ:091990

Watchlist Manager
Celltrion Healthcare Co Ltd
KOSDAQ:091990
Watchlist
Price: 75 900 KRW
Updated: Mar 29, 2024

Intrinsic Value

Celltrion Healthcare Co., Ltd. manufactures pharmaceutical products. [ Read More ]

The intrinsic value of one Celltrion Healthcare Co Ltd stock under the Base Case scenario is 62 877.97 KRW. Compared to the current market price of 75 900 KRW, Celltrion Healthcare Co Ltd is Overvalued by 17%.

Key Points:
Intrinsic Value
Base Case
62 877.97 KRW
Overvaluation 17%
Intrinsic Value
Price
C
Worst Case
Base Case
Best Case

Valuation Backtest
Celltrion Healthcare Co Ltd

Backtest Celltrion Healthcare Co Ltd Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling Celltrion Healthcare Co Ltd stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

How can I assist you today?

Provide an overview
of Celltrion Healthcare Co Ltd's business.

What risks and challenges
does Celltrion Healthcare Co Ltd face in the near future?

Summarize the latest earnings report
of Celltrion Healthcare Co Ltd.

Provide P/E
for Celltrion Healthcare Co Ltd and its competitors.

Financials

Balance Sheet Decomposition
Celltrion Healthcare Co Ltd

Current Assets 4.5T
Cash & Short-Term Investments 433.4B
Receivables 1.3T
Other Current Assets 2.7T
Non-Current Assets 182.2B
Long-Term Investments 2.8B
PP&E 10.3B
Intangibles 12.3B
Other Non-Current Assets 156.8B
Current Liabilities 2.5T
Accounts Payable 1.7T
Accrued Liabilities 87.5B
Short-Term Debt 292.5B
Other Current Liabilities 447.2B
Non-Current Liabilities 135.8B
Long-Term Debt 4.6B
Other Non-Current Liabilities 131.3B
Efficiency

Earnings Waterfall
Celltrion Healthcare Co Ltd

Revenue
2.1T KRW
Cost of Revenue
-1.4T KRW
Gross Profit
620.7B KRW
Operating Expenses
-425.9B KRW
Operating Income
194.8B KRW
Other Expenses
-58.9B KRW
Net Income
136B KRW

Free Cash Flow Analysis
Celltrion Healthcare Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

Profitability Score
Profitability Due Diligence

Celltrion Healthcare Co Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
Positive Operating Income
50/100
Profitability
Score

Celltrion Healthcare Co Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Celltrion Healthcare Co Ltd's solvency score is 78/100. The higher the solvency score, the more solvent the company is.

78/100
Solvency
Score

Celltrion Healthcare Co Ltd's solvency score is 78/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Celltrion Healthcare Co Ltd

Wall Street analysts forecast Celltrion Healthcare Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Celltrion Healthcare Co Ltd is 97 444 KRW .

Lowest
Price Target
Not Available
Average
Price Target
97 444 KRW
28% Upside
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

Price
Celltrion Healthcare Co Ltd

1M 1M
-
6M 6M
+24%
1Y 1Y
+27%
3Y 3Y
-42%
5Y 5Y
+30%
10Y 10Y
+79%
Annual Price Range
75 900
52w Low
59 000
52w High
80 400
Price Metrics
Average Annual Return 26.22%
Standard Deviation of Annual Returns 112.09%
Max Drawdown -68%
Shares Statistics
Market Capitalization 12.2T KRW
Shares Outstanding 164 460 000
Percentage of Shares Shorted
N/A

Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Celltrion Healthcare Co Ltd

Country

Korea

Industry

Health Care

Market Cap

12.2T KRW

Dividend Yield

0%

Description

Celltrion Healthcare Co., Ltd. manufactures pharmaceutical products. The company is headquartered in Incheon, Incheon. The company went IPO on 2017-07-28. The firm provides Remsima, an infliximab biosimilar used for the treatment of rheumatoid arthritis, ankylosing spondylitis, adult and child crohn’s disease, psoriasis, psoriatic arthritis and ulcerative colitis. The company also offers Truxima, a rituximab biosimilar used for the treatment of non-Hodgkin lymphomas, chronic lymphocytic leukemia and rheumatoid arthritis. The firm distributes its products in domestic and overseas markets.

Contact

INCHEON
Incheon
4F, 19, Academy-ro 51beon-gil, Yeonsu-gu
+82328506400
https://www.celltrionhealthcare.com/

IPO

2017-07-28

Employees

-

Officers

Exec. Chairman
Joon Serk Seo
CEO & Exec. Director
Hyoung Ki Kim

See Also

Discover More
What is the Intrinsic Value of one Celltrion Healthcare Co Ltd stock?

The intrinsic value of one Celltrion Healthcare Co Ltd stock under the Base Case scenario is 62 877.97 KRW.

Is Celltrion Healthcare Co Ltd stock undervalued or overvalued?

Compared to the current market price of 75 900 KRW, Celltrion Healthcare Co Ltd is Overvalued by 17%.